NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
36 hedge funds and large institutions have $3.4M invested in Navidea Biopharmaceuticals Inc. in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
46% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 13
Holders
36
Holding in Top 10
–
Calls
$351K
Puts
$377K
Top Buyers
| 1 | +$79.2K | |
| 2 | +$78.7K | |
| 3 | +$31K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$29K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$9.75K |
Top Sellers
| 1 | -$87.2K | |
| 2 | -$48.5K | |
| 3 | -$40.7K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$28.6K |
| 5 |
ACM
Allred Capital Management
Dallas,
Texas
|
-$26.4K |